A Phase III Trial Comparing HRS-8080 With Standard Endocrine Therapy in Patients With High-Risk Early Breast Cancer
Phase 3 Recruiting
4,800 enrolled
RAMP 301
Phase 3 Recruiting
270 enrolled
Morpheus-panBC
Phase 1/2 Recruiting
792 enrolled
DCIS: RECAST Trial Ductal Carcinoma In Situ: Re-Evaluating Conditions for Active Surveillance Suitability as Treatment
Phase 2 Recruiting
400 enrolled
ELEGANCE
Recruiting
2,766 enrolled
OPERA-02
Phase 3 Recruiting
1,000 enrolled
I-SPY
Phase 2 Recruiting
5,000 enrolled
OPERA-01
Phase 3 Recruiting
510 enrolled
FEMUS
Phase 2/3 Recruiting
260 enrolled
Trial of Pre-operative Neratinib and Endocrine Therapy With Trastuzumab in ER-Positive, HER-2 Positive Breast Cancers
Phase 2 Recruiting
30 enrolled
Prototype DAA/TAA Vaccine Targeting MUC1 for Immune Interception and Prevention in Ductal Carcinoma In Situ
Phase 1 Recruiting
50 enrolled
INAVO123
Phase 3 Recruiting
450 enrolled
OMAHA-015
Phase 2 Recruiting
250 enrolled
A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in Participants With Advanced Breast Cancer With a Genetic Change (PIK3CA)
Phase 3 Recruiting
920 enrolled
DEBRA
Phase 3 Recruiting
1,670 enrolled
PIKALO-1
Phase 1/2 Recruiting
720 enrolled
Adjuvant WIDER
Phase 3 Recruiting
1,400 enrolled
FourLight-3
Phase 3 Recruiting
1,020 enrolled
RaPhLRR
Phase 2 Recruiting
200 enrolled
Functional Imaging in Prediction of Response to Abemaciclib for Advanced Hormone Receptor-Positive, HER2-Negative Breast Cancer
Phase 2 Recruiting
60 enrolled
A Study to Test Inavolisib Treatments in Participants With Early-Stage, PIK3CA-Mutated Breast Cancer
Phase 2 Recruiting
60 enrolled
POWER II
Phase 3 Recruiting
354 enrolled
Study of GVV858 as a Single Agent or in Combination With Endocrine Therapy in Patients With HR+/HER2- Breast Cancer and Other Advanced Solid Tumors
Phase 1/2 Recruiting
205 enrolled
IMPULSE
Recruiting
240 enrolled
AVZO-023-1001
Phase 1/2 Recruiting
380 enrolled
Assessing the Efficacy and Safety of Anti-HER2 Therapy in Nigerian Women With HER2+ Breast Cancer Before and After Surgery
Phase 2 Recruiting
74 enrolled